Market Trends of Global Digital Dose Inhaler Industry
This section covers the major market trends shaping the Digital Dose Inhaler Market according to our research experts:
Dry Powder Inhalers (DPI) are Expected to Hold a Major Share in the Growth of the Market Over the Forecast Period
Dry powder inhalers are devices that deliver medication to the lungs in the form of a dry powder. The major factors attributing to the growth of the dry powder inhaler segment are the prevalence of chronic respiratory diseases like COPD, Asthma, etc., and the growing demand for technology-enabled features of respiratory devices.
Problems related to the occurrences of drug irritation caused by the existence of propellant components, such as chlorofluorocarbons (CFCs) in MDI, have boosted the usage of the DPIs, with lesser irritant impacts while providing therapeutic efficacy as MDIs.Hence the DPIs are called green inhalers.
Additionally, the increasing product launches are also expected to contribute to the growth of the studied segment during the forecast period. For instance, in December 2020, Berry Global launched the RS01 single-dose dry powder inhaler with built-in sensors and digital capabilities. The RS01 tracks inhaler use and connects to a companion app that provides personalized guidance to improve adherence and inhaler technique.
Thus the above-mentioned factors are expected to drive the growth of the studied segment during the forecast period.
North America Dominates the Market and Expected to do Same Over the Forecast Period
North America is expected to dominate the overall digital dose inhaler market throughout the forecast period. The increase in the prevalence of respiratory conditions among both the pediatric and the elderly population will further benefit market growth.
In the United States, asthma is more common in adult women than in adult men. According to the Centers for Disease Control and Prevention (CDC) published in May 2022, 7.8% of the population in the United States had prevalent asthma in 2020. The report also mentioned that the prevalence of asthma in females was 9.5% and 6.1% in males in 2020.
Also, the increasing product launches are expected to drive the growth of the market in this region. For instance, in September 2020 Teva Pharmaceuticals launched the AirDuo Digihare and ArmonAir Digihaler inhalation powder, two digital maintenance inhalers for patients with asthma.
Thus the above-mentioned factors are expected to drive the growth of the market during the forecast period in this region.
